Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.38 |
| ▸ | LMNA | P02545 | 3/20 | 0.38 |
| ▸ | METAP1 | P53582 | 3/20 | 0.38 |
| ▸ | CCR1 | P32246 | 2/20 | 0.38 |
| ▸ | CCR5 | P51681 | 2/20 | 0.38 |
| ▸ | CCR8 | P51685 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
| ▸ | DOHH | Q9BU89 | 1/20 | 0.38 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 6/20 | 0.35 |
| ▸ | RAB9A | P51151 | 5/20 | 0.35 |
| ▸ | TP53 | P04637 | 3/20 | 0.34 |
| ▸ | HTT | P42858 | 3/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL820253 | 0.85 | KDM4E (0.38) | KDM4ELMNAMETAP1CCR1CCR5 | |
| SCHEMBL435395 | 0.80 | KDM4E (0.42) | KDM4ELMNAMETAP1CCR1CCR5 | |
| SCHEMBL1311500 | 0.77 | KDM4E (0.39) | KDM4ELMNAMETAP1CCR1CCR5 | |
| SCHEMBL7589588 | 0.76 | KDM4E (0.42) | KDM4ELMNAMETAP1CCR1CCR5 | |
| SCHEMBL15641196 | 0.76 | KDM4E (0.42) | KDM4ELMNAMETAP1CCR1CCR5 | |
| SCHEMBL1312502 | 0.76 | KDM4E (0.38) | KDM4ELMNAMETAP1CCR1CCR5 | |
| SCHEMBL9132747 | 0.75 | KDM4E (0.37) | KDM4ELMNAMETAP1CCR1CCR5 | |
| SCHEMBL6883837 | 0.74 | KDM4E (0.39) | KDM4ELMNAMETAP1CCR1CCR5 | |
| SCHEMBL7123291 | 0.74 | KDM4E (0.36) | KDM4ELMNAMETAP1CCR1CCR5 | |
| SCHEMBL7054134 | 0.73 | KDM4E (0.38) | KDM4ELMNAMETAP1CCR1CCR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4693687-A1 | SEPARATOR OF LITHIUM-ION BATTERY, AND PREPARATION METHOD THEREFOR AND USE THEREOF | SVOLT Energy Technology Co., Ltd. (CN) | 2026-02-11 | — | — | EP | claimed |
| WO-2024217474-A1 | SEPARATOR OF LITHIUM-ION BATTERY, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 蜂巢能源科技股份有限公司 | 2024-10-24 | — | — | WO | claimed |
| CN-118006052-A | Environment-friendly flame-retardant polystyrene composite material and preparation method thereof | 连云港传奇阻燃科技有限公司 | 2024-05-10 | — | — | CN | claimed |
| CN-117531371-B | Microfiltration membrane of MABR membrane element and preparation method thereof | 中源晟朝有限公司 | 2024-04-12 | — | — | CN | claimed |
| CN-117531371-A | Microfiltration membrane of MABR membrane element and preparation method thereof | 中源晟朝有限公司 | 2024-02-09 | — | — | CN | claimed |
| CN-116874745-A | Thiophene derivative conjugated polymer containing amphoteric ions and preparation method and application thereof | 浙江工业大学 | 2023-10-13 | — | — | CN | claimed |
| CN-115490582-B | Preparation method of fluorine-containing biphenyl alkene negative monomer liquid crystal compound | 烟台德润液晶材料有限公司 | 2023-10-10 | — | — | CN | claimed |
| CN-115490582-A | Preparation method of fluorine-containing biphenyl alkene negative monomer liquid crystal compound | 烟台德润液晶材料有限公司 | 2022-12-20 | — | — | CN | claimed |
| US-7709654-B2 | Process for producing oxazole, imidazole, pyrrazole boryl compounds | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) | 2010-05-04 | — | — | US | claimed |
| EP-4693687-A1 | SEPARATOR OF LITHIUM-ION BATTERY, AND PREPARATION METHOD THEREFOR AND USE THEREOF | SVOLT Energy Technology Co., Ltd. (CN) | 2026-02-11 | — | — | EP | disclosed |
| US-12478621-B2 | Substituted aminoquinolones as dgkalpha inhibitors for immune activation | DEUTSCHES KREBSFORSCHUNGSZENTRUM (DE) | 2025-11-25 | — | — | US | disclosed |
| EP-4605393-A1 | TRIAZOLE-SUBSTITUTED IMIDAZO[1,2-A]PYRIMIDINES AS CGAS INHIBITORS | GlaxoSmithKline Intellectual Property Development Limited (GB) | 2025-08-27 | — | — | EP | disclosed |
| US-20250197381-A1 | SUBSTITUTED TETRAHYDROFURANS AS MODULATORS OF SODIUM CHANNELS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2025-06-19 | — | — | US | disclosed |
| US-12331021-B2 | Total synthesis of pirfenidone | Suzhou Fude Zhaofeng Biochemical Technology Co., Ltd (CN) | 2025-06-17 | — | — | US | disclosed |
| US-20160046597-A1 | RORC2 INHIBITORS AND METHODS OF USE THEREOF | PFIZER (US) | 2016-02-18 | — | — | US | disclosed |
| EP-2390241-B1 | METHOD FOR MANUFACTURING CONJUGATED AROMATIC COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2014-10-01 | — | — | EP | disclosed |
| US-8598349-B2 | Method for manufacturing conjugated aromatic compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-12-03 | — | — | US | disclosed |
| EP-2390241-A1 | METHOD FOR MANUFACTURING CONJUGATED AROMATIC COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2011-11-30 | — | — | EP | disclosed |
| US-20110275859-A1 | METHOD FOR MANUFACTURING CONJUGATED AROMATIC COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED | 2011-11-10 | — | — | US | disclosed |
| US-20110256790-A1 | THERMAL INSULATION CONTAINING SUPPLEMENTAL INFRARED RADIATION ABSORBING MATERIAL | SAINT-GOBAIN ISOVER (FR) | 2011-10-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110275859-A1 | METHOD FOR MANUFACTURING CONJUGATED AROMATIC COMPOUND | C9, H1-10, CYP1A1 | KDM4E 724/4885LMNA 1269/4885METAP1 2979/4885 |
| US-20160046597-A1 | RORC2 INHIBITORS AND METHODS OF USE THEREOF | RORC, RORB, RORA | KDM4E 1807/4885LMNA 3310/4885METAP1 2936/4885 |
| US-12478621-B2 | Substituted aminoquinolones as dgkalpha inhibitors for immune activation | DGKK, DGKG, DGKA | KDM4E 1315/4885LMNA 1953/4885METAP1 3401/4885 |
| US-12331021-B2 | Total synthesis of pirfenidone | PIR, CYP2B6, CYP26B1 | KDM4E 386/4885LMNA 4815/4885METAP1 553/4885 |
| US-20250197381-A1 | SUBSTITUTED TETRAHYDROFURANS AS MODULATORS OF SODIUM CHANNELS | TRPV1, TRPA1, SCN2B | KDM4E 2978/4885LMNA 3179/4885METAP1 4157/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.